Study summary · research use only
The optimizing action of the synthetic peptide Selank on a conditioned active avoidance reflex in rats
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
In this rat study, the synthetic heptapeptide Selank was tested on learning and memory using acquisition of a conditioned active avoidance reflex, comparing rats with initially low learning ability to normal rats, with peptide given 15 min before training over four days. Selank (300 microg/kg) was compared with piracetam (400 mg/kg). The authors report that Selank was associated with increased learning in poor-learning rats from the first dose, with a progressive rise in correct responses and fewer errors (p < 0.05) on repeated administration, and that in normal rats the maximum optimizing action appeared on day 3. They relate these findings to previously reported anti-anxiety actions of Selank.
Abstract
The actions of the synthetic heptapeptide preparation Selank on learning and memory processes in rats with initially low levels of learning ability were compared with those in normal rats, using a method based on acquisition of a conditioned active avoidance reflex, with repeated administration of peptide 15 min before the start of training sessions for four days. The effects of Selank (300 microg/kg) were compared with the effects of the nootrope piracetam (400 mg/kg). These experiments showed that Selank significantly activated the learning process in rats with initially poor learning ability, with effects apparent after first dose on training day 1. The effect progressively increased on repeated administration of Selank: the total number of correct solutions increased and the number of errors decreased (p < 0.05). The maximum optimizing activity of Selank on learning in normal rats was seen on day 3 of repeated administration and training, i.e., after formation of the initial consolidation phase. The dynamic features of the development of the activating action of Selank and piracetam were described. Comparison of the results obtained here with data on the anti-anxiety actions of Selank suggested potential for its use in optimizing mnestic functions in conditions of elevated emotional tension.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.